Therapeutic Discovery

Protheragen offers all the solutions for the therapeutic discovery related to the MyD88, such as the development of small molecule inhibitors, monospecific antibodies, siRNA, and mimetic peptides. Our innovation in targeted drug development continues from the early discovery phase through preclinical and IIT support, where we offer hundred percent innovative skills and unique approaches.